Acorda Therapeutics shareholder Millenco cuts stake to less than 5%

By Lisa Kerner

Charlotte, N.C., May 28 - A group of Acorda Therapeutics, Inc. investors led by Millenco LLC reported beneficial ownership of 1,530,877 shares following a series of sell transactions between April 13 and May 27.

Millenco has a 4.0% stake in the Hawthorne, N.Y.-based biopharmaceutical company, according to a schedule 13D/A filed with the Securities and Exchange Commission on Thursday.

In a prior SEC filing, Millenco reported beneficial ownership of 1,801,014 shares following a series of buy and sell transactions between Feb. 9 and April 8.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.